Research Funding

Since 2005, the Children’s Neuroblastoma Cancer Foundation has funded more than $2.5 million in neuroblastoma research and programs. The following is an overview of the grants CNCF has provided by fiscal year.

Dr. Ting Tao: Dana Farber Cancer Institute - The Role of ARID1A in neuroblastoma tumorigenesis
Dr. Bilal Omer: Baylor College of Medicine - Improving immune cell trafficking to neuroblastoma with “scout cells
Dr. Jason Shohet: Baylor College of Medicine - Analysis of p53 responses and regulation by G-CSFin neuroblastoma cancer stem cell subpopulations.
Dr. Julie Park: Seattle Children’s Hospital - MIBG Scoring Project: COGA3973 and SIOPEN-NBL-1
Dr. Sam Volchenboum: Comer Children’s Hospital - “The MYCN Oncogene: Providing Insight to Improved Diagnostic Stratification, Therapeutic Evaluation, and Novel Treatment Design for High-Risk Neuroblastoma."
NANT
SIOPEN
Travel grant for MIBG Scoring Project
MIBG Scoring Project: COGA3973 and SIOPEN-NBL-1
Dr. Susan Cohn, University of Chicago - Interactive International Neuroblastoma Information Network
Dr. Susan Cohn, University of Chicago - Genome-wide Analysis of Favorable Stage Neuroblastoma with MYCN Amplification
Dr. Nai-Kong Cheung, Memorial Sloan Kettering - Humanized 3F8 Research
Dr. Heidi Russell, Texas Children’s Hospital - Pepi Trial
Metin Gurcan PhD, Ohio State University - Computer aided prognosis of Neuroblastoma - 2-year grant
Dr. Kelly Goldsmith, Children’s Hospital of Philadelphia - Polymine Depletion Strategies in Neuroblastoma - 2-year grant
Dr. Eugene Kim, Baylor College of Medicine - The Role of MDM2 in Tumor Angiogenesis in Neuroblastoma - 2-year grant
Dr. Hong Xu, Memorial Sloan Kettering - B7H3: An Immunological Target for Neuroblastoma - 2-year grant
Dr. Barry Mauerer, Texas Tech University - Purchase of Fenretinide
Drs. Seeger/Reynolds, Children’s Hospital LA - Private donation
Dr. Susan Cohn, University of Chicago - Genome-wide Analysis of Favorable Stage Neuroblastomas with MYCN Amplification
Dr. Cynthia van Golen, Delaware State University - Therapeutic Efficacy of Agents Targeting the IGF-IR in HumanNeuroblastoma - 2-year grant
Dr. Elizabeth Beierle, University of Florida/ University of Alabama, Birmingham - Focal Adhesion Kinase and Vascular Endothelial Growth Factor Receptor-3 in Neuroblastoma - 2-year grant
Dr. Tasnim Ara, Children’s Hospital Los Angeles - Contribution of Bone Marrow Microenvironment to Neuroblastoma Chemoresistance and Tumor Progression - 2-year grant
Dr. Alexandre Chlenski, University of Chicago - SPARC-derived peptides for the treatment of Neuroblastoma - 2-year grant
Dr. Kristina Cole, Children’s Hospital of Philadelphia - siRNA Inhibition of the Protein Kinome in Neuroblastoma - 2-year grant
Dr. Nai-Kong Cheung, Memorial Sloan Kettering
Sonia Hernandez, Columbia University - Notch Signaling Pathway and VEGF Blockade in Neuroblastoma - 2-year grant
Dr. Jason Shohet, Baylor College of Medicine - MYCN-regulated MicroRNA Expression in Neuroblastoma - 2-year grant
Drs. Seeger/Reynolds, Children’s Hospital of Los Angeles - Private donation
Dr. Edward Attiyeh, Children’s Hospital of Philadelphia -Genetic basis of aggressive neuroblastoma - 2-year grant
Dr. Louis Chesler, University of CA, San Francisco - Proteomic analysis of serum from children with Neuroblastoma - 2-year grant
Dr. Radoslaw Zagoadzon, Beth Israel Deaconess - Studies on the role of CHK Kinase on Neuroblastoma - 2-year grant

Scroll to Top